|
|
|
KCS10617904
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
19a
|
CAS
|
2940247-68-5
|
|
InChI=1S/C22H22Cl2N4O2S/c23-16-9-14(10-17(24)11-16)13-30-22(29)28-7-5-19(6-8-28)27-18-3-1-15(2-4-18)20-12-26-21(25)31-20/h1-4,9-12,19,27H,5-8,13H2,(H2,25,26)
|
|
ClC1=CC(Cl)=CC(COC(N2CCC(NC3=CC=C(C4=CN=C(N)S4)C=C3)CC2)=O)=C1
|
|
C22H22Cl2N4O2S
|
|
C22H22Cl2N4O2S
|
476.1
|
0
|
C22H22Cl2N4O2S
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-10
|
|
|
|
KCS10617905
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
19b
|
CAS
|
2940247-69-6
|
|
InChI=1S/C22H22Cl2N4O2S/c23-16-8-14(9-17(24)11-16)13-30-22(29)28-6-4-18(5-7-28)27-19-3-1-2-15(10-19)20-12-26-21(25)31-20/h1-3,8-12,18,27H,4-7,13H2,(H2,25,26)
|
|
ClC1=CC(Cl)=CC(COC(N2CCC(NC3=CC(C4=CN=C(N)S4)=CC=C3)CC2)=O)=C1
|
|
C22H22Cl2N4O2S
|
|
C22H22Cl2N4O2S
|
476.1
|
0
|
C22H22Cl2N4O2S
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-12
|
|
|
|
KCS10617906
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
19e
|
CAS
|
2940247-72-1
|
|
InChI=1S/C22H22Cl2N4O2/c23-17-9-15(10-18(24)11-17)13-30-22(29)28-7-5-20(6-8-28)27-19-3-1-16(2-4-19)21-12-25-14-26-21/h1-4,9-12,14,20,27H,5-8,13H2,(H,25,26)
|
|
ClC1=CC(Cl)=CC(COC(N2CCC(NC3=CC=C(C4=CN=CN4)C=C3)CC2)=O)=C1
|
|
C22H22Cl2N4O2
|
|
C22H22Cl2N4O2
|
444.1
|
0
|
C22H22Cl2N4O2
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-12
|
|
|
|
KCS10617907
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
19f
|
CAS
|
2940247-73-2
|
|
InChI=1S/C22H22Cl2N4O2/c23-17-8-15(9-18(24)11-17)13-30-22(29)28-6-4-19(5-7-28)27-20-3-1-2-16(10-20)21-12-25-14-26-21/h1-3,8-12,14,19,27H,4-7,13H2,(H,25,26)
|
|
ClC1=CC(Cl)=CC(COC(N2CCC(NC3=CC(C4=CN=CN4)=CC=C3)CC2)=O)=C1
|
|
C22H22Cl2N4O2
|
|
C22H22Cl2N4O2
|
444.1
|
0
|
C22H22Cl2N4O2
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-12
|
|
|
|
KCS10617908
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
19g
|
CAS
|
2940247-74-3
|
|
InChI=1S/C23H24Cl2N4O2/c1-15-26-13-22(27-15)17-2-4-20(5-3-17)28-21-6-8-29(9-7-21)23(30)31-14-16-10-18(24)12-19(25)11-16/h2-5,10-13,21,28H,6-9,14H2,1H3,(H,26,27)
|
|
ClC1=CC(Cl)=CC(COC(N2CCC(NC3=CC=C(C4=CN=C(C)N4)C=C3)CC2)=O)=C1
|
|
C23H24Cl2N4O2
|
|
C23H24Cl2N4O2
|
458.1
|
0
|
C23H24Cl2N4O2
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-12
|
|
|
|
KCS10617909
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
19i
|
CAS
|
2940247-76-5
|
|
InChI=1S/C23H24Cl2N4O2/c1-15-22(27-14-26-15)17-2-4-20(5-3-17)28-21-6-8-29(9-7-21)23(30)31-13-16-10-18(24)12-19(25)11-16/h2-5,10-12,14,21,28H,6-9,13H2,1H3,(H,26,27)
|
|
ClC1=CC(Cl)=CC(COC(N2CCC(NC3=CC=C(C4=C(C)N=CN4)C=C3)CC2)=O)=C1
|
|
C23H24Cl2N4O2
|
|
C23H24Cl2N4O2
|
458.1
|
0
|
C23H24Cl2N4O2
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-12
|
|
|
|
KCS10617910
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
19j
|
CAS
|
2940247-77-6
|
|
InChI=1S/C23H24Cl2N4O2/c1-15-22(27-14-26-15)17-3-2-4-21(11-17)28-20-5-7-29(8-6-20)23(30)31-13-16-9-18(24)12-19(25)10-16/h2-4,9-12,14,20,28H,5-8,13H2,1H3,(H,26,27)
|
|
ClC1=CC(Cl)=CC(COC(N2CCC(NC3=CC(C4=C(C)N=CN4)=CC=C3)CC2)=O)=C1
|
|
C23H24Cl2N4O2
|
|
C23H24Cl2N4O2
|
458.1
|
0
|
C23H24Cl2N4O2
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-12
|
|
|
|
KCS10617911
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
19l
|
CAS
|
2940247-79-8
|
|
InChI=1S/C23H23Cl2N3O3/c1-15-26-13-22(31-15)17-3-2-4-21(11-17)27-20-5-7-28(8-6-20)23(29)30-14-16-9-18(24)12-19(25)10-16/h2-4,9-13,20,27H,5-8,14H2,1H3
|
|
ClC1=CC(Cl)=CC(COC(N2CCC(NC3=CC(C4=NNC(O4)=O)=CC=C3)CC2)=O)=C1
|
|
C23H23Cl2N3O3
|
|
C21H20Cl2N4O4
|
459.1
|
0
|
C21H20Cl2N4O4
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-12
|
|
|
|
KCS10617912
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
19m
|
CAS
|
2940247-80-1
|
|
InChI=1S/C21H21Cl2N5O2/c22-16-8-14(9-17(23)11-16)13-30-21(29)28-6-4-18(5-7-28)25-19-3-1-2-15(10-19)20-12-24-27-26-20/h1-3,8-12,18,25H,4-7,13H2,(H,24,26,27)
|
|
CC1=NC=C(O1)C2=CC=CC(NC(CC3)CCN3C(OCC4=CC(Cl)=CC(Cl)=C4)=O)=C2
|
|
C21H21Cl2N5O2
|
|
C23H23Cl2N3O3
|
445.1
|
0
|
C23H23Cl2N3O3
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-12
|
|
|
|
KCS10617913
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
19n
|
CAS
|
2940248-04-2
|
|
InChI=1S/C23H24Cl2N4O2/c24-19-8-17(9-20(25)11-19)14-31-23(30)29-6-4-16(5-7-29)12-27-21-3-1-2-18(10-21)22-13-26-15-28-22/h1-3,8-11,13,15-16,27H,4-7,12,14H2,(H,26,28)
|
|
O=C(OCC1=CC(Cl)=CC(Cl)=C1)N2CCC(CC2)CNC3=CC=CC(C4=CN=CN4)=C3
|
|
C23H24Cl2N4O2
|
|
C23H24Cl2N4O2
|
458.1
|
0
|
C23H24Cl2N4O2
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-12
|
|
|
|
KCS10617914
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
27a
|
CAS
|
2940248-11-1
|
|
InChI=1S/C18H19Cl2N7O3/c19-13-5-11(6-14(20)7-13)10-29-18(28)27-3-1-12(2-4-27)16-24-25-17(30-16)21-8-15-9-22-26-23-15/h5-7,9,12H,1-4,8,10H2,(H,21,25)(H,22,23,26)
|
|
ClC1=CC(Cl)=CC(COC(N2CCC(C3=NN=C(NCC4=CN=NN4)O3)CC2)=O)=C1
|
|
C18H19Cl2N7O3
|
|
C18H19Cl2N7O3
|
451.1
|
0
|
C18H19Cl2N7O3
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-12
|
|
|
|
KCS10617915
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
27b
|
CAS
|
2940248-12-2
|
|
InChI=1S/C18H19Br2N7O3/c19-13-5-11(6-14(20)7-13)10-29-18(28)27-3-1-12(2-4-27)16-24-25-17(30-16)21-8-15-9-22-26-23-15/h5-7,9,12H,1-4,8,10H2,(H,21,25)(H,22,23,26)
|
|
O=C(OCC1=CC(Br)=CC(Br)=C1)N2CCC(C3=NN=C(NCC4=CN=NN4)O3)CC2
|
|
C18H19Br2N7O3
|
|
C18H19Br2N7O3
|
539
|
0
|
C18H19Br2N7O3
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-12
|
|
|
|
KCS10617916
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
27c
|
CAS
|
2940248-13-3
|
|
InChI=1S/C20H19F6N7O3/c21-19(22,23)13-5-11(6-14(7-13)20(24,25)26)10-35-18(34)33-3-1-12(2-4-33)16-30-31-17(36-16)27-8-15-9-28-32-29-15/h5-7,9,12H,1-4,8,10H2,(H,27,31)(H,28,29,32)
|
|
O=C(OCC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1)N2CCC(C3=NN=C(NCC4=CN=NN4)O3)CC2
|
|
C20H19F6N7O3
|
|
C20H19F6N7O3
|
519.2
|
0
|
C20H19F6N7O3
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-12
|
|
|
|
KCS10617917
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
27d
|
CAS
|
2940248-14-4
|
|
InChI=1S/C20H25N7O3/c1-13-7-14(2)9-15(8-13)12-29-20(28)27-5-3-16(4-6-27)18-24-25-19(30-18)21-10-17-11-22-26-23-17/h7-9,11,16H,3-6,10,12H2,1-2H3,(H,21,25)(H,22,23,26)
|
|
O=C(OCC1=CC(C)=CC(C)=C1)N2CCC(C3=NN=C(NCC4=CN=NN4)O3)CC2
|
|
C20H25N7O3
|
|
C20H25N7O3
|
411.2
|
0
|
C20H25N7O3
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-12
|
|
|
|
KCS10617918
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
27e
|
CAS
|
2940248-15-5
|
|
InChI=1S/C20H25N7O5/c1-29-16-7-13(8-17(9-16)30-2)12-31-20(28)27-5-3-14(4-6-27)18-24-25-19(32-18)21-10-15-11-22-26-23-15/h7-9,11,14H,3-6,10,12H2,1-2H3,(H,21,25)(H,22,23,26)
|
|
O=C(OCC1=CC(OC)=CC(OC)=C1)N2CCC(C3=NN=C(NCC4=CN=NN4)O3)CC2
|
|
C20H25N7O5
|
|
C20H25N7O5
|
443.2
|
0
|
C20H25N7O5
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-12
|
|
|
|
KCS10617919
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
27f
|
CAS
|
2940248-16-6
|
|
InChI=1S/C18H19F2N7O3/c19-13-5-11(6-14(20)7-13)10-29-18(28)27-3-1-12(2-4-27)16-24-25-17(30-16)21-8-15-9-22-26-23-15/h5-7,9,12H,1-4,8,10H2,(H,21,25)(H,22,23,26)
|
|
O=C(OCC1=CC(F)=CC(F)=C1)N2CCC(C3=NN=C(NCC4=CN=NN4)O3)CC2
|
|
C18H19F2N7O
|
|
C18H19F2N7O3
|
419.2
|
0
|
C18H19F2N7O3
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-12
|
|
|
|
KCS10617920
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
27g
|
CAS
|
2940248-17-7
|
|
InChI=1S/C19H22BrN7O3/c1-12-6-13(8-15(20)7-12)11-29-19(28)27-4-2-14(3-5-27)17-24-25-18(30-17)21-9-16-10-22-26-23-16/h6-8,10,14H,2-5,9,11H2,1H3,(H,21,25)(H,22,23,26)
|
|
O=C(OCC1=CC(Br)=CC(C)=C1)N2CCC(C3=NN=C(NCC4=CN=NN4)O3)CC2
|
|
C19H22BrN7O3
|
|
C19H22BrN7O3
|
475.1
|
0
|
C19H22BrN7O3
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-12
|
|
|
|
KCS10617921
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
27h
|
CAS
|
2940248-18-8
|
|
InChI=1S/C18H19BrClN7O3/c19-13-5-11(6-14(20)7-13)10-29-18(28)27-3-1-12(2-4-27)16-24-25-17(30-16)21-8-15-9-22-26-23-15/h5-7,9,12H,1-4,8,10H2,(H,21,25)(H,22,23,26)
|
|
O=C(OCC1=CC(Br)=CC(Cl)=C1)N2CCC(C3=NN=C(NCC4=CN=NN4)O3)CC2
|
|
C18H19BrClN7O3
|
|
C18H19BrClN7O3
|
495
|
0
|
C18H19BrClN7O3
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-12
|
|
|
|
KCS10617922
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
27i
|
CAS
|
2940248-19-9
|
|
InChI=1S/C18H19ClFN7O3/c19-13-5-11(6-14(20)7-13)10-29-18(28)27-3-1-12(2-4-27)16-24-25-17(30-16)21-8-15-9-22-26-23-15/h5-7,9,12H,1-4,8,10H2,(H,21,25)(H,22,23,26)
|
|
O=C(OCC1=CC(Cl)=CC(F)=C1)N2CCC(C3=NN=C(NCC4=CN=NN4)O3)CC2
|
|
C18H19ClFN7O3
|
|
C18H19ClFN7O3
|
435.1
|
0
|
C18H19ClFN7O3
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-12
|
|
|
|
KCS10617923
|
KAP242324
|
AI-driven drug discovery
|
The ultimate goal of this project is to develop an AI-based drug discovery platform that integrates modules for drug target identification, mechanism-of-action (MoA) prediction, hit and lead compound design, efficacy and off-target prediction, and ADME and toxicity evaluation. The platform will be continuously refined and validated, and ultimately utilized to generate innovative drug candidates with global competitiveness.
|
27j
|
CAS
|
2940248-20-2
|
|
InChI=1S/C18H19Cl2N7O3/c19-13-1-2-15(20)12(7-13)10-29-18(28)27-5-3-11(4-6-27)16-24-25-17(30-16)21-8-14-9-22-26-23-14/h1-2,7,9,11H,3-6,8,10H2,(H,21,25)(H,22,23,26)
|
|
O=C(OCC1=CC(Cl)=CC=C1Cl)N2CCC(C3=NN=C(NCC4=CN=NN4)O3)CC2
|
|
C18H19Cl2N7O3
|
|
C18H19Cl2N7O3
|
451.1
|
0
|
C18H19Cl2N7O3
|
0
|
0
|
|
|
|
합성
|
|
|
|
Yes
|
95
|
LC
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
No
|
|
|
|
0
|
0
|
0
|
|
|
2026-03-12
|